EMEA-000278-PIP01-08-M01
Key facts
Invented name |
PEDIACEL
|
Active substance |
|
Therapeutic area |
Vaccines
|
Decision number |
P/64/2009
|
PIP number |
EMEA-000278-PIP01-08-M01
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Active immunisation against infectious diseases caused by Haemophilus influenzae type b, Corynebacterium diphtheriae, Clostridium tetani, Bordetella pertussis and poliovirus types 1, 2 and 3
|
Route(s) of administration |
Intramuscular use
|
Contact for public enquiries |
Sanofi Pasteur MSD SNC
E-mail: piplan@spmsd.com |
Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|
Compliance procedure number |
EMEA-C-000278-PIP01-08-M01
|
Compliance opinion date |
18/09/2009
|
Compliance outcome |
positive
|